메뉴 건너뛰기




Volumn 152, Issue 3, 2004, Pages 273-274

Writing about creatine: Is it worth the risk?

Author keywords

AIA; amino imidazo azaarene; Cr; creatine; Creatine; Creatine metabolism; Creatine supplementation; Health benefits; Neuroprotection

Indexed keywords

CAFFEINE; CREATINE;

EID: 4344717688     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.05.008     Document Type: Letter
Times cited : (3)

References (12)
  • 1
    • 0036405496 scopus 로고    scopus 로고
    • Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease
    • Blum D., Galas M.-C., Gall D., Cuvelier L., Schiffman S.N. Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease. Neurobiol. Dis. 10:2002;410-426
    • (2002) Neurobiol. Dis. , vol.10 , pp. 410-426
    • Blum, D.1    Galas, M.-C.2    Gall, D.3    Cuvelier, L.4    Schiffman, S.N.5
  • 2
    • 0035095231 scopus 로고    scopus 로고
    • Genomic multi-level nutrient-sensing pathways
    • Brudnak M.A. Genomic multi-level nutrient-sensing pathways. Med. Hypotheses. 56:2001;194-199
    • (2001) Med. Hypotheses , vol.56 , pp. 194-199
    • Brudnak, M.A.1
  • 3
    • 0034913807 scopus 로고    scopus 로고
    • Application of genomeceuticals to the molecular and immunological aspects of autism
    • Brudnak M.A. Application of genomeceuticals to the molecular and immunological aspects of autism. Med. Hypotheses. 57:2001;186-191
    • (2001) Med. Hypotheses , vol.57 , pp. 186-191
    • Brudnak, M.A.1
  • 4
    • 1842427203 scopus 로고    scopus 로고
    • Creatine: Are the benefits worth the risk?
    • Brudnak M.A. Creatine: are the benefits worth the risk? Toxicol. Lett. 150:2004;123-130
    • (2004) Toxicol. Lett. , vol.150 , pp. 123-130
    • Brudnak, M.A.1
  • 5
    • 0036095642 scopus 로고    scopus 로고
    • Opposite actions of caffeine and creatine on muscle relaxation time in humans
    • Hespel P., Op 't Eijnde B., Van Leemputte M. Opposite actions of caffeine and creatine on muscle relaxation time in humans. J. Appl. Physiol. 92:2002;513-518
    • (2002) J. Appl. Physiol. , vol.92 , pp. 513-518
    • Hespel, P.1    Op Eijnde 'T, B.2    Van Leemputte, M.3
  • 6
    • 0009534249 scopus 로고    scopus 로고
    • Placebo-controlled trial of creatine in Huntington's disease
    • Kieburtz K. Huntington Study Group Placebo-controlled trial of creatine in Huntington's disease. Neurology. 56(Suppl. 3):2001;A386
    • (2001) Neurology , vol.56 , Issue.SUPPL. 3 , pp. 386
    • Kieburtz, K.1    Study Group, H.2
  • 11
    • 0033935979 scopus 로고    scopus 로고
    • Creatine and creatinine metabolism
    • Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 80:2000;1107-1213
    • (2000) Physiol. Rev. , vol.80 , pp. 1107-1213
    • Wyss, M.1    Kaddurah-Daouk, R.2
  • 12
    • 0037129967 scopus 로고    scopus 로고
    • Health implications of creatine: Can oral creatine supplementation protect against neurological and atherosclerotic disease?
    • Wyss M., Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neuroscience. 112:2002;243-260
    • (2002) Neuroscience , vol.112 , pp. 243-260
    • Wyss, M.1    Schulze, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.